The Outcomes of NRICM101 on SARS-COV-2 (COVID-19) Infection
Study Details
Study Description
Brief Summary
Traditional Chinese medicine is regarded as a dietary supplement in many countries around the world. Dietary supplement, NRICM101, has been available for people who diagnosed, suspected or prevented for coronavirus disease 2019 (COVID-19) in September 2020. It is expected to help people not to progress to severe illness, and reduce lung damage and mortality. The investigators gather the effects of people who taking NRICM101 using the Real-World Big Data Study and the network feedback information collection model. This study can be used as a reference for global prevention and control of coronavirus disease 2019 (COVID-19).
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is raging around the world. Because of its strong spread, variability, survivability, and invisibility, the number of infected people rise rapidly. On March 11, 2020, the WHO officially declared COVID-19 as a pandemic disease. As of October 3, 2020, the number of confirmed cases has exceeded 34 million, and the cumulative deaths have exceeded 1 million. There are still no drugs to treatment the coronavirus disease 2019 (COVID-19). Due to the mutation of virus rapidly, vaccine development cannot be completed in a short period of time. At the beginning of the infection outbreak, the governments of China and South Korea, adopted a cooperative of Chinese and Western medicine to treatment the coronavirus disease 2019 (COVID-19). In addition to the reported good clinical effects, Chinese medicine prescriptions have included in diagnosis and treatment guideline of these two countries.
Traditional Chinese medicine is regarded as a dietary supplement in many countries around the world. Dietary supplement, NRICM101, has been available for people who diagnosed, suspected or prevented for coronavirus disease 2019 (COVID-19) in September 2020. It is expected to help people not to progress to severe illness, and reduce lung damage and mortality. The investigators gather the effects of people who taking NRICM101 using the Real-World Big Data Study and the network feedback information collection model. This study can be used as a reference for global prevention and control of coronavirus disease 2019 (COVID-19).
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| NRICM101 Subjects who confirmed, suspected or prevented infected of COVID 19 disease and received dietary supplement NRICM101 |
Dietary Supplement: NRICM101
Direction: Take 1 sachet 2-4 times daily directly or with 400cc water before or between meals
Indication: Externally contracted seasonal epidemic
Function: Relieving Exterior and Facilitating Lung, clear heat of lung, Wide chest and resolve phlegm
|
Outcome Measures
Primary Outcome Measures
- negative of COVID-19 test [1 day to 2 months]
receive COVID 19 test and the result is negative
- free of COVID 19 disease symptoms and signs [1 day to 2 months]
free of COVID 19 disease symptoms and signs after took NRICM101
Eligibility Criteria
Criteria
Inclusion Criteria:
- Subjects who confirmed, suspected or prevented infected of COVID 19 disease and take dietary supplement NRICM101
Exclusion Criteria:
- Those who refuse to participate in observational research.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | National Research Institute of Chinese Medicine, Ministry of Health and Welfare | Taipei | Taiwan | 11221 |
Sponsors and Collaborators
- National Research Institute of Chinese Medicine, Ministry of Health and Welfare
Investigators
- Principal Investigator: Yi-Chang Su, MD, PhD, National Research Institute of Chinese Medicine, Ministry of Health and Welfare
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- NRICM101